Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate
Immunocore’s intra-patient dose escalation Phase I IMCgp100 study in metastatic uveal melanoma patients demonstrates a one-year overall survival (OS) rate of 73% (95% confidence interval [46, 88]) and a one-year progression-free-survival (PFS) rate of 62% based on the irRC criteria as of the data cut-off in October 2017. Median OS has not been reached with median follow-up of 12.8 months in this cohort. The overall survival data from this study compare very favourably to studies with other agents, which show one-year OS rates of approximately 25-45%.*
For the full press release: http://glassdoor.com/slink.htm?key=vQDGT
We're world leading and at the cutting edge of some highly sophisticated stuff! ImmTAC molecules are a new class of bi-specific biologic molecules that combine an affinity-enhanced T cell receptor (TCR)-based targeting system with an anti-CD3 (scFv) effector function to activate a highly potent and specific T cell response to recognise and destroy cancer cells.
Ultimately, our work here is about transforming the lives of patients, their families and the wider scientific and medical communities.
We're a very active bunch in all sorts of ways; the sport and social committee are always busy, keeping us... busy. Whether it be: running, cycling, squash, football, yoga, knitting, photography, gardening, badminton... (goes off and makes a cup of tea) ... cake sales, charity 5K's, beer tasting, theatre trips, skiing holidays... (goes off for a nap)... 100K walks, Christmas parties, summer parties... You get the idea.
We even have our ow marketplace for buying and selling!
Getting diversity in to STEM subjects is high on the education agenda. We're pleased to say that in many ways we break conventions in Biotech with 50:50 gender split and over 43 nationalities working across our UK & US sites.
Our very own Eva-Lotta Allan, CBO is considered one of the 15 women leading Biotech in Europe.
I have been working at Immunocore full-time (More than a year)
Company genuinely care about employees. Great work environment. Chance to contribute with your work to develop a new, cutting edge therapeutic platform.
Pay could be better considering the cost of life in this area of the country.
I applied online. The process took 4+ weeks. I interviewed at Immunocore (Abingdon, England) in April 2016.
The interview was a disgrace. I felt unwelcome from the moment I was called into the meeting room. There was no 'hello' or 'how was your journey' or any icebreaker pleasantries as you would expect. The 4 interviewers appeared to be laughing at me and giving each other conspiring, shifty looks when I walked in, and tried to stifle their laughs (albeit not very well). Whether they were laughing at me (my mannerisms are a little unorthodox, admittedly) or some inside joke (such as a blanket-emailed viral skateboarding cat video), I will never know. It was still incredibly unprofessional, insulting and intimidating. Needless to say, this absolutely undermined my performance for the rest of the interview. To put it frankly, it reminded me of cliquey children teasing in a playground. These were senior managers! ABSOLUTELY SHOCKING!
The rest of the interview was not very pleasant either. Throughout the entire interview, they seemed hellbent to to catch me out with their questions. Normally, an interview is a pleasant professional 2-way dynamic dialogue in which both interviewer and interviewee say their piece, but this was far from that. They were very cold and unfriendly throughout. I could tell that I wasn't welcome there. My feeling is that they already had a (possibly internal) candidate in mind, and they only called me so they could fulfill an interview quota (and get some light entertainment out of it).
Through previous email correspondence with HR, I was informed beforehand that there would be a lab tour after. And yet, as the interview was drawing to a close after (what seemed like) 20 minutes, I could tell that the interviewers were ready to bid me farewell. So I had to ask for a lab tour, as promised in the email. At that point, the interviewers looked hesitantly at each other as though they had been greatly inconvenienced, but agreed. The gentleman showing me around was warm, friendly and helpful, in stark contrast to the interviewers. The lab looked busy and well-equipped and (aside from the harrowing interview) seemed like a place I would like to work.
As shocked and appalled as I was by the interviewers' behaviour, I sincerely believe that it was not representative of Immunocore as a company. Immunocore is an innovative biotech company with a pipeline of ImmTAC biotherapeutics focussing on a range of immuno-oncology diseases. ImmTACs are bi-specific molecules with both anti-CD3 scFv for tumour recognition and T-cell receptor to activate a T-cell response to destroy cancer cells. I applaud Immunocore's work and would have genuinely loved to have contributed towards this.
The experience was so traumatic, I cried on the train journey home. It shattered my spirits for days to come. What hurt the most was not being taken seriously. For them, it might be another 20 minutes in the meeting room tick-box checklisting just another candidate who they have no intention of hiring. For me, it was several weeks of intense preparation and psyching myself up, not to mention travelling half-way across the country for this kangaroo court of an interview.
Needless to say, even if offered the role, I would not accept it!
A message to hiring managers: Please conduct yourself well in an interview, because as well as assessing candidates, you too will be assessed, and your conduct reflects that of the company! Please take recruitment seriously and don't joke around in the interview room. Please save it for tea breaks or Friday after-work drinks down the pub. There is a time and place for recalling that cat video, or the revelry of last years Xmas party, but the interview room is not the place! Please treat every interviewee with dignity and respect. Please attempt to see beyond the exterior of the individual, without preconception, prejudging or stereotyping. 'Weird' is not necessarily bad. Sometimes, the most unlikely borderline-case candidates may turn out to be the most suitable new hires!